Michelle Perugini AI speaker

Dr Michelle Perugini

Keynote Speaker

Dr Michelle Perugini is an entrepreneur, academic and an internationally renowned expert in health, medical research, advanced analytics, and cognitive AI. Michelle spent the first 13 years of her career in health and medical research, specialising in predictive genetics and translational medicine. Michelle led large complex research projects that translated genetic mutation analysis (bioinformatics) to clinical treatments for cancer patients. She was also the pioneer of new methods in proteomics that now drive drug discovery.

Based in Adelaide
Book Dr Michelle Perugini Now

Description

Michelle Perugini AI speaker sessions come from an entrepreneur, academic and internationally renowned expert in health, medical research and advanced AI technologies. She holds a PhD in Medicine. She also spent over a decade in oncology research before transitioning into industry. There, she founded two global AI technology companies. One of these was acquired by EY in 2015.

As Co-Founder and CEO of Presagen, Michelle led the development of a world-first federated AI platform for medical data. Its flagship product, Life Whisperer, improved IVF outcomes and was commercialised in 48 countries. Astec Co. acquired the business in 2024. Today, she serves as Board Chair of Qubigen, a company advancing AI-driven drug design using federated AI. She is also Director of Research Translation and Commercialisation at Adelaide University and CEO of UniSA Ventures, where she leads the strategic translation of university research into real-world impact.

Michelle Perugini AI Speaker: Expertise and Topics

Book Michelle Perugini AI speaker to explore the real-world application of artificial intelligence in health and medicine. She draws on her experience translating university research into commercial impact. In this role, she drives industry engagement and investor partnerships. She also guides the commercial development of innovative technologies emerging from academic research. Michelle is a dedicated advisor to many start-ups and a member of numerous government committees. In addition, she is an avid supporter of the AI and women’s health sectors globally.

Michelle has shared the stage with leaders across medical AI and innovation, including panels on medical AI at La Trobe University and the Women’s Health Innovation Summit in the USA. Audiences consistently value her ability to translate complex AI and medical research into practical, real-world insight for boards, executives and investors alike.

See Michelle Perugini’s full profile, expertise and topics on the Corporate Speakers Australia speaker page, or browse other AI keynote speakers.

Showreel

In 2007 Michelle co-founded the innovative start-up ISD Analytics where she led the research and development, and commercialisation, of its award¬ winning human-population behaviour predictive analytics software product Simulait. ISD Analytics was acquired by Ernst & Young (EY) in 2015 and became one of EY’s global suite of analytics products.

Michelle is now working with and mentoring various innovative technology start-ups, and is a co-founder and CEO of Presagen and Life Whisperer.

Presagen is changing the way medical data from around the world is connected with artificial intelligence, to build globally scalable and unbiased medical products across all industries in healthcare. Presagen’s AI Open Projects in an online platform that safely connects data from clinics globally to co-develop medical AI products that can be delivered at scale and at low cost.

Presagen’s first product is Life Whisperer. Life Whisperer uses artificial intelligence (AI) to better identify healthy embryos for IVF, and to ultimately improve outcomes for couples wanting to have children.

Related Speakers